SELLAS Life Sciences Group, Inc. (SLS)
NASDAQ · Manufacturing · Pharmaceutical preparations
$11.60−$0.3800 (−3.17%) on the dayAs of the close; data may be delayed.
SLS price, last 12 months
Key stats
- Previous close
- $11.98
- Open
- $11.97
- Day range
- $11.50 – $12.15
- 52-week range
- $1.39 – $15.88
- Volume
- 4.2M
- Avg volume (20 days)
- 6.8M
- Market cap
- $2.3B
Performance
1W+1.0%
1M−15.5%
3M−6.4%
6M+134.3%
YTD+207.7%
1Y+611.7%
vs S&P 500, 1Y+594.9 pts
Technicals and fundamentals
About SELLAS Life Sciences Group, Inc.
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $2.3B